Leukocytes >= 2,500/mcL
Leukocytes >= 1,500/mcL
Leukocytes >= 2,500/mcL, within 2 weeks of randomization
Leukocytes >= 3,000/mcL
Within 14 days of treatment initiation: Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/ mm^3
Leukocytes >= 3000/mm^3 must be obtained =< 7 days prior to protocol registration
Leukocytes >= 3,000/mm^3
Within less than or equal to 14 days prior to registration: Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL within 4 weeks before randomization
Leukocytes >= 3,000/mcL
leukocytes ?3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes ? 3,000/mcL within 14 days of registration
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes ? 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL (>= 3,000/mm^3)
Leukocytes >= 2,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes >= 3.0 x 10^9/L
Leukocytes >= 3,000/mcL
PIK3CA WILD TYPE COHORT (closed 03/17/2016): Leukocytes >= 3,000/mcL
ENDOCRINE RESISTANT AND ADJUVANT COHORT: Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes > 3,000/mcL
Leukocytes ? 3,000/mcL
Obtained within 21 days prior to study registration: leukocytes >= 3,000/mcL
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 1,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcl
Leukocytes >= 3,000/uL
Leukocytes >= 2,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Within 2 weeks prior to initiation of study treatment: Leukocytes >= 3,000/mcL
COHORT I: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3 x 10^9/L
Leukocytes ? 2,000/mcL
Leukocytes >= 3,000/mcL.
Leukocytes >= 3,000/mcL, =< 5 days prior to cycle 1 (C1) day 1 (D1)
Leukocytes >= 3,000/mcL.
Leukocytes >= 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL.
Leukocytes <3.0 x 109/L
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mm^3
Leukocytes ? 3,000/uL
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL.
Leukocytes >= 3,000/mcL within 14 days of treatment initiation
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Obtained within 21 days of registration: leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL 14 days or fewer from registration
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL (without growth factor)
Leukocytes >= 3,000/mcL
Less than 5% malignant cells in the peripheral blood leukocytes
Leukocytes >= 1500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3 x 10^9/L
Leukocytes >= 1500/mcL, within 14 days prior to treatment
Leukocytes >= 3000 mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mL
Leukocytes >= 2,000/mcL
Leukocytes > 3,000/uL
Leukocytes >= 3,000/mcL
PHASE II: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Within 14 days prior to registration: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL, obtained within 14 days of first dose of drug
Leukocytes > 3,000/uL
Leukocytes >= 3,000/uL
PHASE I: Leukocytes >= 3,000/mcL
PHASE II SCLC: Leukocytes >= 3,000/mcL
UROTHELIAL CARCINOMA EXPANSION COHORT: Leukocytes >= 3,000/mcL
mCRPC EXPANSION COHORT: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000 cells/mm^3
Leukocytes >= 3,000/mcL
Less than 5% malignant cells in the peripheral blood leukocytes
Leukocytes: >= 3,000/mcl (lymphocyte [lymph] %: >= 10%)
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL obtained within 14 days of first treatment
Leukocytes >= 3,000/mcL
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes < 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 2500/mL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/ul
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 1,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/ÂµL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/uL (within 2 weeks prior to radiotherapy)
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mL
Within 4 weeks of preregistration: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >3,000/mcL
Leukocytes ? 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 1,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000 per mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mm^3, obtained =< 7 days prior to registration
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 1,500/mcL
Leukocytes >= 3,000/mcL
DOSE ESCALATION COHORT: Leukocytes ? 3,000/mcL
DOSE EXPANSION COHORT: Leukocytes ? 3,000/mcL
Leukocytes >= 3,000/mcL
Measured within 28 days prior to administration of study treatment: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Secondary Registration: leukocytes >= 3,000/uL
Leukocytes >= 3,500/mcL
Leukocytes > 3,000/uL
Within 14 days of registration: Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Less than 5% plasma cells in the peripheral blood leukocytes
Leukocytes >= 3,000/mcL
PHASE II: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL; these results must be obtained within 28 days prior to registration
Leukocytes no lower limit
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 4,000/ul
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000 per mm^3
Obtained within 30 days of registration: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL, within 14 days of study registration
Leukocytes >= 2,000/mcL
Leukocytes >= 2,000/uL
Leukocytes >= 3,000/uL
Leukocytes >= 3.0 x 10^9/L
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/?L
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL (labs should be performed within 14 days of treatment initiation)
Leukocytes >= 3000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes greater than 3,000/mcL
Leukocytes >= 3,000/mL
Leukocytes >= 3,000/microL
Leukocytes >= 3,000/mcL
PHASE I: Leukocytes >= 3,000/mcL
PHASE II: Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 2,000/mcL
Leukocytes > 3,000/uL
PART B: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes > 3,000/mcL
REGISTRATION INCLUSION CRITERIA: Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/uL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes ? 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes ? 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 2,500/mcL
Leukocytes >= 2,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >3,000/mm3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes: >= 3,000/mm^3
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mm^3
Leukocytes > 1,500/mcL
Leukocytes > 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes: >= 3,000/ul
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,00/mcL
Performed within 10 days of treatment initiation: Leukocytes >= 2,000/mcL
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/microliter (mcL)
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,500/mcL
Leukocytes >= 2,500/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3 K/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 2,000/mcL
Leukocytes >= 3000/uL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mm^3
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/mcL
Leukocytes: >= 3,000/mm^3
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/microliter
Leukocytes >= 2,500/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 2,500/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/uL
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/microliter
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/microliter
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL (within 14 days of study registration)
Leukocytes > 3,000/uL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mL
Leukocytes >= 3,000 /uL
Leukocytes ? 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes >= 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes > 3,000/mcL
Leukocytes >= 3,000/mcL
